Cost: Non-members: $65 | Member: $35 | Student: $15
Bronchiolitis and asthma are two of the most common conditions leading to hospitalization and death in the neonatal and pediatric populations. Research is also showing a strong link between RSV bronchiolitis infection during infancy and the development of reactive airway disease later in life. It is important that any clinician recognize the signs of respiratory compromise and distress before it leads to respiratory failure. Clinicians will need to determine the appropriate interventions and level of care for the child presenting to clinic with these conditions. Many clinicians overreact when they see a child with increased work of breathing, and it is important they gain the knowledge and become more comfortable with treating children who are experiencing respiratory compromise and or distress.
The goal of this presentation is to arm the clinician with the knowledge they will need to recognize and care for any child in acute respiratory compromise or distress. This presentation aims make the clinician feel more comfortable caring for these patients. They will also gain insight on how to educate patients and families regarding anticipatory guidance, strict return to clinic precautions, and when to go seek further care and respiratory support in an emergency department. This presentation will also review the most up-to-date, evidenced-based, clinical pathway guidelines to assist in the treatment of these conditions in the outpatient setting.
**This presentation is worth 1 Category 1 CE credit, including 0.35 Pharmacology credit, for Washington-licensed NDs.**
Originally presented May 6th, 2023, at WANP's CONNECT 2023 conference.